Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Y015910 | — |
Nurse confirmed no symptomatic adverse events that she was aware of; administration of pediatric VAQTA to an adult 64 year old patient; This spontaneous report was received from a nurse and refers to a 64-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-Aug-2025, the patient was vaccinated with a pediatric dose of Hepatitis A Vaccine, Inactivated (VAQTA) (lot #Y015910, expiration date: 06-Feb-2026), dose number 1, (0.5 ml / once), (anatomical location and administration route were not reported) administered as prophylaxis. The reporting nurse called to report administration of a pediatric Hepatitis A Vaccine, Inactivated (VAQTA) to an adult 64-year-old patient. Nurse confirmed no symptomatic adverse events that she was aware of.